Israel Englander Wave Life Sciences Ltd. Transaction History

Millennium Management LLC

$175 Billion
Q1 2025

A detailed history of Israel Englander (Millennium Management LLC) transactions in Wave Life Sciences Ltd. stock. As of the latest transaction made, Millennium Management LLC holds 26,222 shares of WVE stock, worth $210,038. This represents 0.0% of its overall portfolio holdings.

Number of Shares

26,222

Previous 1,180,838 97.78%

Holding current value

$210,038

Previous $14.6 Million 98.56%

% of portfolio

0.0%

Previous 0.01%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$8.08 - $13.51 $9.33 Million - $15.6 Million	-1,154,616 Reduced 97.78%	26,222 $211,000
Q4 2024 Feb 14, 2025	BUY	$8.0 - $16.44 $2.63 Million - $5.41 Million	329,173 Added 38.65%	1,180,838 $14.6 Million
Q3 2024 Nov 14, 2024	SELL	$5.12 - $9.01 $4.16 Million - $7.32 Million	-812,635 Reduced 48.83%	851,665 $6.98 Million
Q2 2024 Aug 14, 2024	BUY	$4.38 - $6.48 $125,662 - $185,911	28,690 Added 1.75%	1,664,300 $8.3 Million
Q1 2024 May 15, 2024	BUY	$3.54 - $6.84 $3.97 Million - $7.67 Million	1,121,029 Added 217.85%	1,635,610 $10.1 Million
Q4 2023 Feb 14, 2024	SELL	$4.16 - $6.87 $1.03 Million - $1.7 Million	-246,808 Reduced 32.42%	514,581 $2.6 Million
Q2 2023 Aug 14, 2023	SELL	$3.51 - $4.69 $2.34 Million - $3.13 Million	-667,102 Reduced 46.7%	761,389 $2.77 Million
Q1 2023 May 15, 2023	BUY	$3.58 - $6.3 $396,889 - $698,436	110,863 Added 8.41%	1,428,491 $6.19 Million
Q4 2022 Feb 14, 2023	BUY	$3.18 - $7.0 $2.42 Million - $5.32 Million	760,071 Added 136.32%	1,317,628 $9.22 Million
Q3 2022 Nov 14, 2022	SELL	$2.37 - $4.28 $1.23 Million - $2.21 Million	-517,476 Reduced 48.14%	557,557 $2.01 Million
Q2 2022 Aug 15, 2022	BUY	$1.23 - $3.25 $380,039 - $1 Million	308,975 Added 40.33%	1,075,033 $3.49 Million
Q1 2022 May 16, 2022	SELL	$2.0 - $3.28 $652,080 - $1.07 Million	-326,040 Reduced 29.85%	766,058 $1.53 Million
Q4 2021 Feb 14, 2022	BUY	$3.14 - $5.15 $32,134 - $52,705	10,234 Added 0.95%	1,092,098 $3.43 Million
Q3 2021 Nov 15, 2021	SELL	$4.89 - $7.12 $272,206 - $396,341	-55,666 Reduced 4.89%	1,081,864 $5.3 Million
Q2 2021 Aug 16, 2021	BUY	$5.65 - $7.47 $4.33 Million - $5.72 Million	766,048 Added 206.21%	1,137,530 $7.58 Million
Q1 2021 May 17, 2021	BUY	$5.61 - $12.01 $1.43 Million - $3.07 Million	255,344 Added 219.86%	371,482 $2.08 Million
Q4 2020 Feb 16, 2021	BUY	$6.99 - $9.26 $709,380 - $939,751	101,485 Added 692.59%	116,138 $914,000
Q3 2020 Nov 16, 2020	SELL	$8.49 - $19.54 $923,151 - $2.12 Million	-108,734 Reduced 88.12%	14,653 $124,000
Q2 2020 Aug 14, 2020	BUY	$7.44 - $11.29 $917,999 - $1.39 Million	123,387 New	123,387 $1.28 Million
Q1 2020 May 14, 2020	SELL	$6.94 - $14.22 $272,984 - $559,343	-39,335 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$7.99 - $37.6 $222,705 - $1.05 Million	27,873 Added 243.18%	39,335 $315,000
Q3 2019 Nov 14, 2019	SELL	$19.17 - $27.4 $156,408 - $223,556	-8,159 Reduced 41.58%	11,462 $235,000
Q2 2019 Aug 15, 2019	SELL	$22.93 - $42.84 $1.27 Million - $2.37 Million	-55,217 Reduced 73.78%	19,621 $512,000
Q1 2019 May 14, 2019	BUY	$32.69 - $47.91 $1.98 Million - $2.91 Million	60,721 Added 430.13%	74,838 $2.91 Million
Q4 2018 Feb 14, 2019	SELL	$37.1 - $50.11 $2.68 Million - $3.62 Million	-72,232 Reduced 83.65%	14,117 $593,000
Q3 2018 Nov 14, 2018	BUY	$36.35 - $55.2 $3.14 Million - $4.77 Million	86,349 New	86,349 $4.32 Million
Q2 2018 Aug 14, 2018	SELL	$33.85 - $50.65 $278,280 - $416,393	-8,221 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$32.45 - $54.7 $266,771 - $449,688	8,221 New	8,221 $330,000
Q4 2017 Feb 14, 2018	SELL	$21.8 - $39.35 $964,453 - $1.74 Million	-44,241 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$16.4 - $25.05 $725,552 - $1.11 Million	44,241	44,241 $962,000

Others Institutions Holding WVE

# of Institutions

206

Shares Held

125M

Call Options Held

499K

Put Options Held

180K

View Full List

About Wave Life Sciences Ltd.

Ticker WVE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,820,096
Market Cap $695M
Description
Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...

More about WVE

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account